Although tumor bud count, stroma type, and the CDX2 expression status in tumor buds were identified as risk factors for LNM, only tumor bud count was significantly correlated with local recurrence in patients with pT1 CRC. The gene discussed is CDX2; the disease is colorectal carcinoma.